← MedPlain
HomeMedications

Symvess (ACELLULAR TISSUE ENGINEERED VESSEL)

Symvess (ACELLULAR TISSUE ENGINEERED VESSEL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Symvess; Generic name: ACELLULAR TISSUE ENGINEERED VESSEL; Manufacturer: Humacyte Global, Inc..

Brand nameSymvess
Generic nameACELLULAR TISSUE ENGINEERED VESSEL
ManufacturerHumacyte Global, Inc.
Used for1 INDICATIONS AND USAGE SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. ( 1 )
Dosage2 DOSAGE AND ADMINISTRATION For surgical vascular implantation only. SYMVESS is administered by surgical implantation to replace the injured extremity artery. The anatomical location and length are decided upon at the discretion of the implanting surgeon and based on the appropriate preoperative clinical evaluation, vessel mapping and/or imaging. ( 2.1 ) SYMVESS may be trimmed to provide the length required for each vascular repair. Additionally, a single SYMVESS can be cut into different length
WarningsWARNING: GRAFT FAILURE Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. [See Warnings and Precautions (5.1 , 5.2) ] WARNING: GRAFT FAILURE See full prescribing information for complete boxed warning. Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. ( 5.1 , 5.2 )
Active ingredient(s)ACELLULAR TISSUE ENGINEERED VESSEL
RouteINTRAVASCULAR
Official labelhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15e9e29f-5aa6-4fc6-b0fe-a48cd1473418

🔍 Search all medications →